RNA - Balance Sheet - Avidity Biosciences, Inc.

Current Liabilities	98 M
Accounts Payable	8.46 M
Short-Term Debt	3.84 M
Other Current Liabilities	85.7 M
Non-Current Liabilities	40.9 M
Long-Term Debt	2.96 M
Other Non-Current Liabilities	38 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	219.9	185.1	340.4	405.5	328.1	94.6	3.1
Short Term Investments	1 281.6	410.3	270.3	85.1	6.7	0	0
Receivables	28.2	1.1	0	0.9	1.2	0	0
Inventory	0	0	0	(0.9)	(1.2)	0	0
Other Current Assets	40.8	14.9	8.3	5.6	3.5	1.1	0.3
Total Current Assets	1 542.3	611.3	622.9	411.1	331.7	95.7	3.2
PP&E	18.3	16.7	15.0	15.6	1.5	0.6	0.7
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0.3	0.3	0.3	0	0
Other Long Term Assets	3.3	0.6	0.6	0.6	0.5	0.6	38 K
Other Assets	0	0	0	0	0	0	0
Total Assets	1 563.9	628.6	638.8	427.6	333.9	96.9	4.0
LIABILITIES
Accounts Payable	8.5	8.8	4.6	2.8	7.7	2.3	1.6
Short Term Debt	3.8	14.8	6.2	3.5	0	2.8	2.7
Other Current Liabilities	64.7	39.9	60.9	28.0	3.2	1.3	0.3
Total Current Liabilities	98.0	80.7	51.9	29.7	14.6	10.2	4.6
Long Term Debt	3.0	6.2	15.2	19.9	1.9	2.2	7.6
Deferred Tax Income	0	0	(1.2)	(6.5)	(12.2)	134.7	0
Other Liabilities	0	0	(7.6)	(10.0)	(0.9)	45 K	32.9
Total Liabilities	138.9	127.8	60.7	46.1	27.7	162.3	45.1
EQUITY
Common Stock	12 K	8 K	7 K	5 K	4 K	1 K	0.4
Retained Earnings	(893.1)	(570.8)	(358.5)	(184.5)	(66.5)	(22.2)	(41.6)
Other Accumulative Comprehensive Income/Loss	2.9	0.1	(2.7)	(0.2)	5 K	(134.7)	(33.1)
Total Equity	1 425.0	500.8	578.1	381.4	306.2	(65.4)	(41.1)
Total Liabilities and Equity	1 563.9	628.6	638.8	427.6	333.9	96.9	4.0
SHARES OUTSTANDING
Common Shares Outstanding	111.6	73.0	52.2	41.4	21.7	37.5	20.7

Free